Clinical Trials Browser

Suspended × Gynecologic × 90 days × Clear all

Neoplasm Metastasis, Ovarian Neoplasms

NCT05000294 2026-02-18

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

BreastEndocrineGastrointestinalGenitourinaryGynecologicNETSarcoma

Bile Duct Neoplasms, Breast Neoplasms, Gallbladder Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vulvar Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT03065062 2026-02-13

Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors

Phase 1 Suspended

75 enrolled

GastrointestinalGynecologicHead & Neck

Head and Neck Neoplasms, Neoplasms, Pancreatic Neoplasms, Endometrial Neoplasms

NCT03875144 2026-02-09

MESOTIP

Phase 2 Suspended

66 enrolled

Gynecologic

Peritoneal Neoplasms

NCT06666218 2026-01-14

Helping Ovarian Cancer Patients Cope With Their Illness (HOPE)

Phase NA Suspended

60 enrolled

Gynecologic

Ovarian Neoplasms

Clinical Trials

Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors

MESOTIP

Helping Ovarian Cancer Patients Cope With Their Illness (HOPE)